Source:http://linkedlifedata.com/resource/pubmed/id/10679688
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2000-3-24
|
pubmed:abstractText |
This study was carried out to determine the effect of recombinant human bone morphogenetic protein (rhBMP) pharmacokinetics (PK) on rhBMP-induced osteoinductive activity. It was our working hypothesis that the PK of a rhBMP significantly affects its osteoinductive activity. The PK of various rhBMPs (rhBMP-2, rhBMP-4, rhBMP-6, and chemically modified rhBMP-2) implanted with four biomaterial carries (Helistat, hDBM, Osteograf/N, and Dexon) was determined using (125)I-labeled proteins in the rat ectopic assay. A select combination of rhBMP and carriers then was evaluated in the rat ectopic assay for osteoinductive activity using a semi-quantitative histologic scoring system. The results indicate that initial protein retention is dependent on protein isoelectric point (pI); proteins with a higher pI yielded a higher implant retention. Subsequent PK was not strongly dependent on the pI or on the carrier. Because of the difference in early retention, the rhBMP-carrier combinations exhibited a >100-fold difference in implant-retained protein dose. When rhBMP-2 and rhBMP-4 were implanted with the carriers, more rhBMP-2 was retained in an implant, and the osteoinductive potency of rhBMP-2 typically was higher than rhBMP-4 at low implantation doses. We conclude that protein pI plays a significant role in the local retention of implanted rhBMP and that higher retention yields a higher osteoinductive activity.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0021-9304
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2000 John Wiley & Sons, Inc.
|
pubmed:issnType |
Print
|
pubmed:volume |
50
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
227-38
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10679688-Amino Acid Sequence,
pubmed-meshheading:10679688-Animals,
pubmed-meshheading:10679688-Biocompatible Materials,
pubmed-meshheading:10679688-Bone Morphogenetic Proteins,
pubmed-meshheading:10679688-Bone Remodeling,
pubmed-meshheading:10679688-CHO Cells,
pubmed-meshheading:10679688-Cricetinae,
pubmed-meshheading:10679688-Drug Carriers,
pubmed-meshheading:10679688-Drug Delivery Systems,
pubmed-meshheading:10679688-Humans,
pubmed-meshheading:10679688-Molecular Sequence Data,
pubmed-meshheading:10679688-Rats,
pubmed-meshheading:10679688-Recombinant Proteins
|
pubmed:year |
2000
|
pubmed:articleTitle |
Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model.
|
pubmed:affiliation |
Department of Biomedical Engineering, 10-102 Clinical Sciences Building, University of Alberta, Edmonton, AB T6G 2G3. hasan.uludag@ualberta.ca
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|